BackgroundChromatin-modifying systems regulate transcriptional programs essential for human neurodevelopment through dynamic modification of histones, DNA, and higher-order chromatin architecture. Pathogenic variants affecting these systems give rise to chromatinopathies, a heterogeneous group of disorders characterised by consistent neurological features, including intellectual disability, developmental delay, autism spectrum disorder, epilepsy, and language impairment, alongside directional va